AR222645A1 - Procedimiento para preparar un 3-oxo-4alfa,5alfa-epoxi-10,13-dimetil-esteroide-2alfa-carbonitrilo - Google Patents
Procedimiento para preparar un 3-oxo-4alfa,5alfa-epoxi-10,13-dimetil-esteroide-2alfa-carbonitriloInfo
- Publication number
- AR222645A1 AR222645A1 AR274829A AR27482978A AR222645A1 AR 222645 A1 AR222645 A1 AR 222645A1 AR 274829 A AR274829 A AR 274829A AR 27482978 A AR27482978 A AR 27482978A AR 222645 A1 AR222645 A1 AR 222645A1
- Authority
- AR
- Argentina
- Prior art keywords
- esteroide
- 4alfa
- carbonitrilo
- 2alfa
- 5alfa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0063—Nitrogen and oxygen at position 2(3)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/862,417 US4160027A (en) | 1977-12-20 | 1977-12-20 | Steroid cyanoketones and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR222645A1 true AR222645A1 (es) | 1981-06-15 |
Family
ID=25338450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR274829A AR222645A1 (es) | 1977-12-20 | 1978-12-15 | Procedimiento para preparar un 3-oxo-4alfa,5alfa-epoxi-10,13-dimetil-esteroide-2alfa-carbonitrilo |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4160027A (fr) |
| JP (2) | JPS5488253A (fr) |
| AR (1) | AR222645A1 (fr) |
| AT (1) | AT367070B (fr) |
| AU (1) | AU518997B2 (fr) |
| BE (1) | BE872886A (fr) |
| CA (1) | CA1121340A (fr) |
| CH (1) | CH637409A5 (fr) |
| DE (1) | DE2855091A1 (fr) |
| DK (1) | DK156727C (fr) |
| ES (1) | ES476117A1 (fr) |
| FI (1) | FI66010C (fr) |
| FR (1) | FR2412569A1 (fr) |
| GB (2) | GB2010278B (fr) |
| HK (1) | HK89287A (fr) |
| IE (1) | IE48076B1 (fr) |
| IL (1) | IL56076A (fr) |
| IT (1) | IT1195258B (fr) |
| LU (1) | LU80673A1 (fr) |
| MX (1) | MX5535E (fr) |
| NL (1) | NL190848C (fr) |
| NO (1) | NO151467C (fr) |
| NZ (1) | NZ189035A (fr) |
| PH (2) | PH14778A (fr) |
| PT (1) | PT68926A (fr) |
| SE (1) | SE433221B (fr) |
| ZA (1) | ZA786746B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4349474A (en) * | 1981-07-27 | 1982-09-14 | G. D. Searle & Co. | 2-Cyanosteroids |
| JPS5995300A (ja) * | 1982-11-02 | 1984-06-01 | スタ−リング・ドラッグ・インコ−ポレ−テッド | コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物 |
| DK23984A (da) * | 1983-02-11 | 1984-08-12 | Hoffmann La Roche | D-homosteroider |
| US4459235A (en) * | 1983-03-03 | 1984-07-10 | G. D. Searle & Co. | 2-Cyanosteroids |
| GB8328929D0 (en) * | 1983-10-29 | 1983-11-30 | Sterwin Ag | Steroid compounds |
| GB8404980D0 (en) * | 1984-02-25 | 1984-03-28 | Sterwin Ag | Steroid compound |
| DE3531903A1 (de) * | 1985-09-05 | 1987-03-12 | Schering Ag | Oxytocin und antigestagen zur einleitung der geburt bzw. zum therapeutischen abbruch der graviditaet |
| US4755595A (en) * | 1985-11-01 | 1988-07-05 | Sterling Drug Inc. | Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation |
| US4870068A (en) * | 1986-05-22 | 1989-09-26 | Sterling Drug Inc. | Method of regulating fertility in swine using epostane |
| US4833133A (en) * | 1986-05-22 | 1989-05-23 | Sterling Drug Inc. | Method of regulating fertility in cattle using epostane |
| US5795881A (en) * | 1987-06-16 | 1998-08-18 | Schering Aktiengesellschaft | Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type |
| US5215978A (en) * | 1989-06-16 | 1993-06-01 | The Upjohn Company | Method of enhancing egg laying in turkeys using epostane |
| JPH0538929A (ja) * | 1991-08-02 | 1993-02-19 | Mitsubishi Heavy Ind Ltd | 車両用空気調和装置 |
| GB2375958B (en) * | 2001-04-09 | 2005-03-02 | George Margetts | The use of steroids to lower the levels of cortisol |
| GB2414238B (en) * | 2004-05-22 | 2006-12-13 | Stegram Pharmaceuticals Ltd | Method for the preparation of trilostane |
| WO2007009087A2 (fr) * | 2005-07-12 | 2007-01-18 | Dmi Biosciences, Inc. | Procedes et produits de traitement de maladies |
| BRPI1010086A2 (pt) * | 2009-06-22 | 2018-02-06 | Dmi Acquisition Corp | método e produtos para tratamento de doenças |
| PT2554174E (pt) * | 2009-06-22 | 2015-12-15 | Ampio Pharmaceuticals Inc | Método para o tratamento de doenças |
| SG10201705044YA (en) | 2012-12-19 | 2017-07-28 | Ampio Pharmaceuticals Inc | Method for treatment of diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3296255A (en) * | 1963-11-29 | 1967-01-03 | Sterling Drug Inc | 2-cyano steroids |
| US3980638A (en) * | 1974-09-20 | 1976-09-14 | The Upjohn Company | Testosterone derivatives |
| US4062954A (en) * | 1976-12-27 | 1977-12-13 | Sterling Drug Inc. | Process for using a steroid compound |
-
1977
- 1977-12-20 US US05/862,417 patent/US4160027A/en not_active Expired - Lifetime
-
1978
- 1978-11-28 NZ NZ189035A patent/NZ189035A/xx unknown
- 1978-11-29 IL IL56076A patent/IL56076A/xx unknown
- 1978-12-01 ZA ZA00786746A patent/ZA786746B/xx unknown
- 1978-12-04 PH PH21883A patent/PH14778A/en unknown
- 1978-12-08 GB GB7847737A patent/GB2010278B/en not_active Expired
- 1978-12-08 GB GB8116136A patent/GB2088878B/en not_active Expired
- 1978-12-13 AT AT0888578A patent/AT367070B/de not_active IP Right Cessation
- 1978-12-13 CA CA000317885A patent/CA1121340A/fr not_active Expired
- 1978-12-14 MX MX787593U patent/MX5535E/es unknown
- 1978-12-15 AR AR274829A patent/AR222645A1/es active
- 1978-12-18 PT PT68926A patent/PT68926A/pt unknown
- 1978-12-18 LU LU80673A patent/LU80673A1/fr unknown
- 1978-12-18 IE IE2492/78A patent/IE48076B1/en unknown
- 1978-12-19 SE SE7813067A patent/SE433221B/sv not_active IP Right Cessation
- 1978-12-19 CH CH1294978A patent/CH637409A5/fr not_active IP Right Cessation
- 1978-12-19 ES ES476117A patent/ES476117A1/es not_active Expired
- 1978-12-19 IT IT31011/78A patent/IT1195258B/it active
- 1978-12-19 NO NO784281A patent/NO151467C/no unknown
- 1978-12-19 DK DK569678A patent/DK156727C/da not_active IP Right Cessation
- 1978-12-19 FI FI783901A patent/FI66010C/fi not_active IP Right Cessation
- 1978-12-19 NL NL7812309A patent/NL190848C/xx not_active IP Right Cessation
- 1978-12-20 DE DE19782855091 patent/DE2855091A1/de active Granted
- 1978-12-20 JP JP15813378A patent/JPS5488253A/ja active Granted
- 1978-12-20 FR FR7835775A patent/FR2412569A1/fr active Granted
- 1978-12-20 BE BE1009202A patent/BE872886A/fr not_active IP Right Cessation
-
1979
- 1979-06-28 AU AU42089/78A patent/AU518997B2/en not_active Expired
- 1979-09-28 PH PH23081A patent/PH16835A/en unknown
-
1986
- 1986-11-26 JP JP61281639A patent/JPS62142198A/ja active Granted
-
1987
- 1987-12-03 HK HK892/87A patent/HK89287A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES497084A0 (es) | Un procedimiento para preparar nuevos compuestos de tiazol. | |
| ES507972A0 (es) | Un procedimiento para preparar compuestos de cefem . | |
| MX5132E (es) | Procedimiento para preparar un alcano de bispiridinio | |
| AR222645A1 (es) | Procedimiento para preparar un 3-oxo-4alfa,5alfa-epoxi-10,13-dimetil-esteroide-2alfa-carbonitrilo | |
| ES493061A0 (es) | Un procedimiento para preparar un lipopolisacarido | |
| ES490166A0 (es) | Un procedimiento para preparar mercaptoacildipeptidos | |
| ES486425A0 (es) | Un procedimiento para preparar nuevas 4-arilpiperinas. | |
| AR224494A1 (es) | Un procedimiento para preparar cefalexina de accion prolongada | |
| ES497301A0 (es) | Un procedimiento para preparar 9-aminoalquilfluorenos | |
| MX4323E (es) | Procedimiento para preparar un aminoglicosido de 2-deoxiestreptamina | |
| ES475101A0 (es) | Un procedimiento para preparar un parasiticida | |
| IT7821997A0 (it) | Procedimento per preparare idrossietil-amido, adatto come plasma-expander. | |
| ES494459A0 (es) | Un procedimiento para preparar cetoximinoeteres | |
| ES490101A0 (es) | Un procedimiento para obtener 2,6-diaminonebularinas | |
| ES493798A0 (es) | Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona | |
| MX4598E (es) | Procedimiento para preparar una 6a,10a-cis-hexa-hidrodibenzopirona | |
| ES493760A0 (es) | Un procedimiento para preparar benzoxazepinas. | |
| MX5434E (es) | Procedimiento para preparar cicloprofilcarboxilatos | |
| AR211122A1 (es) | Un procedimiento para preparar nuevos compuestos de 4,4-difenil -2- hidrixo-1-aminobutano. | |
| ES482092A0 (es) | Un procedimiento para preparar derivados de la ergolin. | |
| MX5208E (es) | Procedimiento para preparar diclorovinilciclobutanonas | |
| IT7826632A0 (it) | Procedimento per la preparazione di un ciclopentendione. | |
| ES481212A0 (es) | Un procedimiento para preparar benzoxepinas | |
| ES494226A0 (es) | Procedimiento para preparar un 1,2,4-triazol-3-tiol | |
| MX4779E (es) | Procedimiento para preparar di-n-propila-cetonitrilo |